Tag: Trump
Top 20 global biopharma companies report 5.7% fall in market capitalization...
Tariffs, pricing pressures erode $200 billion in value for top biopharma firms; Alnylam and Novartis buck the trend with strong gains
India’s pharma exports surpass USD 30 Billion in FY2025 and aim...
The Rubix report further points to a clear shift in strategic priorities among Indian pharma firms, particularly as global risks mount
USA’s Reciprocal Tariff : Decoding the Impact on Indian Food and...
Sectors like processed foods, sugar, cocoa, and spices may need to strategize to mitigate the adverse effects of these tariffs, writes Dhruv Saxena, Senior Consultant, Frost & Sullivan
Trump’s NIH funding cuts & freezes raise concerns over US biotech...
According to GlobalData’s Pharma Intelligence Center Grants Database, SBIR and STTR grants involving innovator drugs saw a 37% increase in total grant value from $237 million in 2020 to $326 million in 2024
Pharmapack Predictions 2025: the Good the Bad and…. the Donald 2.0
Biologic approvals, drug delivery advancements, GLP-1 generics and the long-sought funding return to drive a record year in 2025